摘要
Abstract
Objective To Explore the Imaging and serum tumor markers in diagnosis and pathological typing of lung cancer. Methods 135 patients in our hospital In 2010 March -2013 year in March were collected, which were diagnosed by operation or biopsy of 83 cases of lung cancer, for lung cancer group, 52 cases were diagnosed lung benign disease patients, as benign group. 50 cases the same normal physical examination were Select as normal group. all peoples were objectived with imaging and serum tumor markers. Results NSE in lung cancer group, SCC-Ag, Cyfra21-1 detection and combined detection of the positive detection rate was higher than the differences between benign group (P<0.01). The positive rate of lung cancer imaging examination is higher than the normal group (P < 0.01), but lower than that in benign group(x2=23.59,P < 0.01),lung cancer group and benign group (combined imaging +NSE+SCC-Ag+Cyfra21-1) positive rate was higher than the normal group (P < 0.05). Squamous cell carcinoma,adenocarcinoma,small cell carcinoma were compared among the three groups,the positive rate of NSE in small cell carcinoma was significantly higher than that in squamous cell carcinoma, adenocarcinoma (P < 0.05). Squamous cell carcinoma SCC-Ag and Cyfra21-1 positive rate was significantly higher than that of adenocarcinoma, small cell carcinoma (P < 0.05). While the NSE+SCC-Ag+Cyfra21-1 joint examination, imaging examination, comparative examination+NSE+SCC-Ag+Cyfra21 seventy percent off sword image, no significant difference (P>0.05). Conclusion Imaging and serum tumor markers joint inspection can significantly improve the sensitivity and accuracy in the diagnosis of lung cancer.关键词
肿瘤标志物/SCC-Ag/NSE/Cyfra21-l/肺癌/影像学检查/病理分型Key words
Tumor marker/Serum SCC-Ag/NSE/Cyfra21-l/Lung cancer/Imaging examination/Pathological type分类
医药卫生
